Management of Patients with Diabetes and Co-existing Psychiatric Disorders
Coordinated management of diabetes and serious mental illness is essential to achieve diabetes treatment targets, requiring enhanced monitoring and support for diabetes self-management behaviors. 1
Screening and Assessment
- Conduct annual screening for depressive symptoms in all patients with diabetes, especially those with a self-reported history of depression, using age-appropriate depression screening measures 1
- Begin assessment for depression at diagnosis of complications or when significant changes in medical status occur 1
- Screen for disordered or disrupted eating using validated screening measures when hyperglycemia and weight loss are unexplained based on self-reported behaviors 1
- Monitor cognitive capacity throughout the lifespan for all individuals with diabetes, particularly in those with documented cognitive disabilities, history of severe hypoglycemia, very young children, and older adults 1
- Annually screen people who are prescribed atypical antipsychotic medications for prediabetes or diabetes 1
Management Approach for Specific Psychiatric Conditions
Depression
- Refer patients with positive depression screens to mental health providers with experience using cognitive behavioral therapy, interpersonal therapy, or other evidence-based approaches 1
- Consider that patients with recent psychiatric illness may have poorer metabolic control (higher HbA1c levels) and report more symptoms of poor metabolic control 2
Serious Mental Illness (particularly schizophrenia and thought disorders)
- Provide increased level of support through enhanced monitoring of and assistance with diabetes self-management behaviors 1
- Include a nonmedical caretaker in decision-making regarding the medical regimen when a person has a mental illness that impacts judgment and ability to establish a collaborative relationship with care providers 1
- Consider remote monitoring, facilitating health care aides, and providing diabetes training for family members and caregivers 1
Eating Disorders
- Re-evaluate the treatment regimen of people with diabetes who present with symptoms of disordered eating behavior or eating disorders 1
- Consider adjunctive medication such as glucagon-like peptide 1 receptor agonists, which may help individuals meet glycemic targets and regulate hunger and food intake 1
- Be cautious in labeling individuals with diabetes as having a diagnosable psychiatric disorder when disordered eating patterns may be associated with physiologic disruption in hunger and satiety cues 1
Medication Considerations
- If a second-generation antipsychotic medication is prescribed for adolescents or adults with diabetes, carefully monitor changes in weight, glycemic control, and cholesterol levels every 12-16 weeks 1
- Adjust treatment regimen as needed based on metabolic changes 1
- Be aware that antipsychotics with noradrenergic activity have the highest potential to cause metabolic abnormalities, with clozapine and olanzapine posing the highest risk 3
Common Pitfalls and Caveats
- Avoid mislabeling patients as "difficult" when they may be experiencing diabetes distress, which differs from psychiatric disorders like depression 4
- Recognize the bidirectional relationship between diabetes and psychiatric disorders - both influencing each other in multiple ways 5
- Be aware that the overall report of diabetes symptoms may be influenced primarily by the presence of psychiatric disorders rather than actual metabolic control 2
- Consider that patterns of maladaptive food intake may be driven by physiologic disruption rather than psychological factors 1
Integrated Care Approach
- Implement coordinated management of diabetes and psychiatric conditions through collaborative care with the patient's diabetes treatment team 1
- Incorporate active monitoring of diabetes self-care activities into treatment goals for people with diabetes and serious mental illness 1
- Consider group support, accountability, and assistance with applying diabetes knowledge as beneficial approaches for patients with both conditions 1